Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders

All antipsychotics currently used in clinic block D2 dopamine receptors. Trace amine-associated receptor 1 is emerging as a new therapeutic target for schizophrenia and several other neuropsychiatric disorders. SEP-363856 (International Nonproprietary Name: Ulotaront) is an investigational antipsych...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuvarzin, Savelii R., Sukhanov, Ilya, Onokhin, Kirill, Zakharov, Konstantin, Gainetdinov, Raul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377193/
https://www.ncbi.nlm.nih.gov/pubmed/37509616
http://dx.doi.org/10.3390/biomedicines11071977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377193/
https://www.ncbi.nlm.nih.gov/pubmed/37509616
http://dx.doi.org/10.3390/biomedicines11071977

Ejemplares similares